Page last updated: 2024-08-21

cepharanthine and Kahler Disease

cepharanthine has been researched along with Kahler Disease in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Harada, N; Hata, H; Kamizaki, Y; Kikukawa, Y; Mitsuya, H; Nakamura, M; Okuno, Y; Tatetsu, H; Ueno, S	1
Nagai, T; Tabata, C; Tabata, R; Tazoh, A	1

Reviews

1 review(s) available for cepharanthine and Kahler Disease

Article	Year
Low dose cepharanthine ameliorates immune thrombocytopenic purpura associated with multiple myeloma. International immunopharmacology, 2012, Volume: 13, Issue:3 Topics: Aged; Benzylisoquinolines; Humans; Immunoglobulin G; Male; Melphalan; Multiple Myeloma; Platelet Count; Prednisolone; Purpura, Thrombocytopenic, Idiopathic	2012

Other Studies

1 other study(ies) available for cepharanthine and Kahler Disease

Article	Year
Induction of cell cycle arrest and apoptosis in myeloma cells by cepharanthine, a biscoclaurine alkaloid. International journal of oncology, 2008, Volume: 33, Issue:4 Topics: Aged; Alkaloids; Antineoplastic Agents, Phytogenic; Apoptosis; Benzylisoquinolines; Caspases; Cell Cycle; Cell Line, Tumor; Dose-Response Relationship, Drug; Enzyme Inhibitors; Female; Humans; Multiple Myeloma; Prognosis; Reactive Oxygen Species	2008

Article

Year

Induction of cell cycle arrest and apoptosis in myeloma cells by cepharanthine, a biscoclaurine alkaloid.

International journal of oncology, 2008, Volume: 33, Issue:4

Topics: Aged; Alkaloids; Antineoplastic Agents, Phytogenic; Apoptosis; Benzylisoquinolines; Caspases; Cell Cycle; Cell Line, Tumor; Dose-Response Relationship, Drug; Enzyme Inhibitors; Female; Humans; Multiple Myeloma; Prognosis; Reactive Oxygen Species

2008